1. Attending to Warning Signs of Primary Immunodeficiency Diseases Across the Range of Clinical Practice
- Author
-
Ricardo U. Sorensen, Francisco J. Espinosa-Rosales, Lily E. Leiva, Antonio Condino-Neto, Mathias Oleastro, Alejandra King, Anete Sevciovic Grumach, Liliana Bezrodnik, Oscar Porras, Beatriz Tavares Costa-Carvalho, and José Luis Franco
- Subjects
medicine.medical_specialty ,Recurrent infections ,Primary immunodeficiencies ,CIENCIAS MÉDICAS Y DE LA SALUD ,Immunology ,Autoimmunity ,Medicina Clínica ,Infections ,Medical microbiology ,recurrent infections ,purl.org/becyt/ford/3.2 [https] ,medicine ,cancer ,warning signs ,Humans ,Immunology and Allergy ,Intensive care medicine ,IMUNOLOGIA ,Cancer ,Inflammation ,Primary immunodeficiency ,business.industry ,Diagnostic Tests, Routine ,autoimmunity ,Immunologic Deficiency Syndromes ,medicine.disease ,Recurrent infection ,Clinical Practice ,Warning signs ,inflammation ,PIDD ,purl.org/becyt/ford/3 [https] ,Medicina Critica y de Emergencia ,business ,Cancer risk ,Key Review Article - Abstract
Purpose: Patients with primary immunodeficiency diseases (PIDD) may present with recurrent infections affecting different organs, organ-specific inflammation/autoimmunity, and also increased cancer risk, particularly hematopoietic malignancies. The diversity of PIDD and the wide age range over which these clinical occurrences become apparent often make the identification of patients difficult for physicians other than immunologists. The aim of this report is to develop a tool for educative programs targeted to specialists and applied by clinical immunologists. Methods: Considering the data from national surveys and clinical reports of experiences with specific PIDD patients, an evidence-based list of symptoms, signs, and corresponding laboratory tests were elaborated to help physicians other than immunologists look for PIDD. Results: Tables including main clinical manifestations, restricted immunological evaluation, and possible related diagnosis were organized for general practitioners and 5 specialties. Tables include information on specific warning signs of PIDD for pulmonologists, gastroenterologists, dermatologists, hematologists, and infectious disease specialists. Conclusions: This report provides clinical immunologists with an instrument they can use to introduce specialists in other areas of medicine to the warning signs of PIDD and increase early diagnosis. Educational programs should be developed attending the needs of each specialty. Fil: Costa Carvalho, Beatriz Tavares. Universidade Federal de São Paulo; Brasil Fil: Sevciovic Grumach, Anete. Fundação ABC. Faculdade de Medicina; Brasil Fil: Franco, José Luis. Universidad de Antioquia; Colombia Fil: Espinosa Rosales, Francisco Javier. Instituto Nacional de Pediatría. Unidad de Investigación en Inmunodeficiencias; México Fil: Leiva, Lily E.. State University of Louisiana; Estados Unidos Fil: King, Alejandra. Hospital de Niños Doctor Luis Calvo Mackenna. Unidad de Inmunología; Chile Fil: Porras, Oscar. Hospital Nacional de Niños “Dr. Carlos Sáenz Herrera”; Costa Rica Fil: Bezrodnik, Liliana. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Oleastro, Mathias. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina Fil: Sorensen, Ricardo U.. State University of Louisiana; Estados Unidos. Universidad de La Frontera. Facultad de Medicina; México Fil: Condino Neto, Antonio. Universidade de Sao Paulo; Brasil
- Full Text
- View/download PDF